-
3 Pharma Companies Receive Positive EU Opinions
Friday, September 16, 2016 - 10:07am | 415Read More...Pfizer Inc. (NYSE: PFE), Amgen, Inc. (NASDAQ: AMGN) and Eli Lilly and Co (NYSE: LLY) received favorable opinions from the European Medicines Agency in response to their respective applications. Pfizer's IBRANCE® Pfizer disclosed that the European Medicines Agency (EMA)'s Committee for Medicinal...
-
Amicus Therapeutics Gains 3% On Favorable EU Medicines Recommendation
Friday, April 1, 2016 - 2:37pm | 392Read More...Shares of Amicus Therapeutics, Inc. (NASDAQ: FOLD), a bio-pharmaceutical company that focuses on the treatment of rare and orphan diseases, were trading higher by 3 percent Friday afternoon. Amicus Therapeutics announced earlier in the day that the European Committee for Medicinal Products for...
-
Leerink Comments On Orexigen Therapeutics, Says Current Projections Could Prove To Be 'Conservative'
Wednesday, March 4, 2015 - 1:01pm | 110Read More...In a report published Wednesday, Leerink analyst Paul Matteis commented on Orexigen Therapeutics, Inc. (NASDAQ: OREX) and wrote that following a positive opinion from the CHMP, the company expects a final opinion from the EMA on the Mysimba (Contrave) marketing authorization application. Matteis...
